title: Evaluation of the risk of pelvic infection following transvaginal oocyte recovery.
abstract: The risk of introducing infection into the peritoneal cavity at the time of transvaginal ultrasound-guided recovery of oocytes in assisted reproduction techniques was assessed by culturing peritoneal fluid samples from 25 women with unexplained infertility. The samples were collected laparoscopically at the time of zygote intra-Fallopian transfer (ZIFT), 24-48 h after oocyte collection. High vaginal and endocervical specimens from 25 women treated by in-vitro fertilization (IVF) and transcervical embryo transfer were cultured for comparison. The peritoneal cultures were negative in all but one patient. High vaginal swabs grew Candida albicans in three cases and endocervical specimens were all negative. Seven and three pregnancies occurred in the ZIFT and IVF groups respectively. No pelvic damage was noted at laparoscopy in those women who had had previous treatment cycles with transvaginal oocyte recovery. This method of oocyte recovery, using prophylactic metronidazole and chlorhexidine for preoperative vaginal preparation, appears to be safe for treatment of women with no previous pelvic damage.
authors.affiliation: Academic Department of Obstetrics and Gynaecology, Royal Free Hospital, Hampstead, London, UK.
authors.forename: P
authors.initials: P
authors.lastname: Curtis
authors.forename: N
authors.initials: N
authors.lastname: Amso
authors.forename: E
authors.initials: E
authors.lastname: Keith
authors.forename: A
authors.initials: A
authors.lastname: Bernard
authors.forename: R W
authors.initials: RW
authors.lastname: Shaw
mesh_terms: D000328:Adult; D001202:Ascitic Fluid / Q000382:microbiology; D001424:Bacterial Infections / Q000453:epidemiology / Q000209:etiology; D002469:Cell Separation; D002584:Cervix Uteri / Q000382:microbiology; D002690:Chlamydia Infections / Q000453:epidemiology / Q000209:etiology; D004624:Embryo Transfer / Q000379:methods; D005069:Evaluation Studies as Topic; D005260:Female; D005307:Fertilization in Vitro; D006801:Humans; D009865:Oocytes; D000292:Pelvic Inflammatory Disease / Q000453:epidemiology / Q000209:etiology*; D011183:Postoperative Complications / Q000453:epidemiology*; D011446:Prospective Studies; D011897:Random Allocation; D012306:Risk; D014621:Vagina / Q000382:microbiology / Q000601:surgery*